PUBLISHER: Persistence Market Research | PRODUCT CODE: 1442693
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1442693
Metered Dose Inhalers Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
Persistence Market Research has recently published an in-depth analysis of the global metered dose inhalers market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the metered dose inhalers market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.
The market for metered dose inhalers is anticipated to grow at a compound annual growth rate (CAGR) of 4.9%, leading to a rise from US$28.2 billion in 2023 to US$39.4 billion by the conclusion of 2030.
- Key Insights:
Metered Dose Inhalers Market Size (2023E): US$28.2 Bn
Projected Market Value (2030F): US$39.4 Bn
Global Market Growth Rate (CAGR 2023 to 2030): 4.9%
Historical Market Growth Rate (CAGR 2018 to 2022): 4.4%
Metered Dose Inhalers Market- Report Scope:
Metered dose inhalers play a crucial role in administering respiratory medications, delivering precise aerosol doses. These handheld devices are commonly used for conditions like asthma and COPD, providing immediate relief or long-term maintenance. Their portability and ease of use make them popular for managing respiratory disorders.
The global market for metered dose inhalers is rapidly growing due to factors such as the increasing prevalence of respiratory diseases, advancements in inhaler technology (like breath-actuated devices and intelligent inhalers), and collaborative efforts in pharmaceutical research for novel formulations and improved designs. This expansion is driven by the need for effective inhalation treatments and the recognition of timely identification and control of respiratory ailments.
- Market Growth Drivers:
The global metered dose inhalers market has seen substantial growth driven by continuous advancements in inhaler formulation and design. Pharmaceutical companies, collaborating with academic institutions, have led the development of MDI technologies, resulting in innovative solutions. The emergence of intelligent inhalers is a groundbreaking development, incorporating digital technology and sensors to provide real-time medication usage data to healthcare providers. This enhances patient engagement, adherence, and allows for personalized treatment plans. The data-driven approach not only improves patient outcomes but also optimizes healthcare resources through focused and efficient interventions.
- Market Restraints:
Environmental concerns related to propellants, especially hydrofluoroalkane (HFA), remain a significant restraint for the global metered dose inhalers market due to their high global warming potential. Pressure from environmental awareness and regulations is pushing the pharmaceutical industry towards more sustainable alternatives.
Another challenge is the increasing complexity of regulatory compliance, particularly in validating and commercializing new inhaler technologies. Manufacturers face stringent criteria for safety, efficacy, and environmental impact, making approval procedures intricate and demanding thorough information on product efficacy, patient safety, and ecological consequences.
- Market Opportunities:
The global metered dose inhalers market presents opportunities through the expanding use of connected devices in respiratory care and the rise of digital health solutions. Smart inhalers, equipped with sensors, collect data on usage patterns and adherence rates. Integration with mobile apps and cloud platforms offers instant insights for healthcare providers and patients. This enhances patient engagement, treatment outcomes, and facilitates personalized interventions. Connected devices contribute to a paradigm shift, providing individualized feedback, medication reminders, and educational materials for active respiratory condition management.
Key Questions Answered in the Report:
- What are the key factors driving the growth of the metered dose inhalers market?
- Which industry verticals are driving the demand for metered dose inhalers?
- How are technological advancements reshaping the competitive landscape of the metered dose inhalers market?
- Who are the leading players in the global metered dose inhalers market?
- What are the emerging trends and future prospects in the global metered dose inhalers market?
Competitive Intelligence and Business Strategy:
Key players in the Metered Dose Inhalers industry, such as Teva Pharmaceutical Industries, GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim, focus on maintaining market dominance through strategic approaches. Significant investments in research and development drive innovation in inhaler technologies, emphasizing improved drug delivery, user-friendliness, and adherence. For instance, GlaxoSmithKline highlights the Ellipta inhaler for its simplicity and effectiveness, while AstraZeneca prioritizes digital health solutions to enhance patient engagement. Global expansion is a common tactic, with a focus on regions with high respiratory disease prevalence, including emerging markets in the Asia Pacific. Strategies involve portfolio diversification, strategic alliances, global market penetration, and continuous innovation.
- Key Companies Profiled:
- Cipla Inc.
- Presspart Manufacturing Ltd.
Midascare Pharmaceuticals Pvt. Ltd.
- Beximco Pharma Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.
- 3M Pharmaceuticals Pty Ltd.
Biocare Manufacturing Sdn Bhd.
Anomatic Innovation & Design Center & Manufacturing
- Aristo Pharma Ltd.
Metered Dose Inhalers Market Segmentation:
- By Type:
- Reliever Inhaler
Long-acting bronchodilators Inhaler
- By End Use:
- Homecare
- Hospitals
- Clinics
- By Region:
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Metered Dose Inhalers Market Snapshot, 2023 and 2030
- 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Type Lifecycle Analysis
- 2.4. Metered Dose Inhalers Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
- 2.5. Porter Five Force's Analysis
- 2.6. Geopolitical Tensions: Market Impact
- 2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
- 2.8. Forecast Factors - Relevance and Impact
- 2.9. Regulatory and Technology Landscape
3. Global Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
- 3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
- 3.3. Global Metered Dose Inhalers Market Outlook: Type
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 3.3.3.1. Reliever Inhaler
- 3.3.3.2. Long-Acting Bronchodilators Inhaler
- 3.4. Market Attractiveness Analysis: Type
- 3.5. Global Metered Dose Inhalers Market Outlook: End User
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 3.5.3.1. Homecare
- 3.5.3.2. Hospitals
- 3.5.3.3. Clinics
- 3.6. Market Attractiveness Analysis: End User
4. Global Metered Dose Inhalers Market Outlook: Region
- 4.1. Key Highlights
- 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
- 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
- 4.4. Market Attractiveness Analysis: Region
5. North America Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 5.1. Key Highlights
- 5.2. Pricing Analysis
- 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Type
- 5.3.3. By End User
- 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
- 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 5.5.1. Reliever Inhaler
- 5.5.2. Long-Acting Bronchodilators Inhaler
- 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.6.1. Homecare
- 5.6.2. Hospitals
- 5.6.3. Clinics
- 5.7. Market Attractiveness Analysis
6. Europe Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 6.1. Key Highlights
- 6.2. Pricing Analysis
- 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Type
- 6.3.3. By End User
- 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
- 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 6.5.1. Reliever Inhaler
- 6.5.2. Long-Acting Bronchodilators Inhaler
- 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.6.1. Homecare
- 6.6.2. Hospitals
- 6.6.3. Clinics
- 6.7. Market Attractiveness Analysis
7. East Asia Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 7.1. Key Highlights
- 7.2. Pricing Analysis
- 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Type
- 7.3.3. By End User
- 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
- 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 7.5.1. Reliever Inhaler
- 7.5.2. Long-Acting Bronchodilators Inhaler
- 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.6.1. Homecare
- 7.6.2. Hospitals
- 7.6.3. Clinics
- 7.7. Market Attractiveness Analysis
8. South Asia & Oceania Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 8.1. Key Highlights
- 8.2. Pricing Analysis
- 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Type
- 8.3.3. By End User
- 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
- 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 8.5.1. Reliever Inhaler
- 8.5.2. Long-Acting Bronchodilators Inhaler
- 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.6.1. Homecare
- 8.6.2. Hospitals
- 8.6.3. Clinics
- 8.7. Market Attractiveness Analysis
9. Latin America Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 9.1. Key Highlights
- 9.2. Pricing Analysis
- 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Type
- 9.3.3. By End User
- 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 9.5.1. Reliever Inhaler
- 9.5.2. Long-Acting Bronchodilators Inhaler
- 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.6.1. Homecare
- 9.6.2. Hospitals
- 9.6.3. Clinics
- 9.7. Market Attractiveness Analysis
10. Middle East & Africa Metered Dose Inhalers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 10.1. Key Highlights
- 10.2. Pricing Analysis
- 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Type
- 10.3.3. By End User
- 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
- 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
- 10.5.1. Reliever Inhaler
- 10.5.2. Long-Acting Bronchodilators Inhaler
- 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.6.1. Homecare
- 10.6.2. Hospitals
- 10.6.3. Clinics
- 10.7. Market Attractiveness Analysis
11. Competition Landscape
- 11.1. Market Share Analysis, 2022
- 11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Type Capacity
- 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Cipla Inc.
- 11.3.1.1. Overview
- 11.3.1.2. Segments and Type
- 11.3.1.3. Key Financials
- 11.3.1.4. Market Developments
- 11.3.1.5. Market Strategy
- 11.3.2. Presspart Manufacturing Ltd
- 11.3.2.1. Overview
- 11.3.2.2. Segments and Type
- 11.3.2.3. Key Financials
- 11.3.2.4. Market Developments
- 11.3.2.5. Market Strategy
- 11.3.3. Midascare Pharmaceuticals Pvt. Ltd
- 11.3.3.1. Overview
- 11.3.3.2. Segments and Type
- 11.3.3.3. Key Financials
- 11.3.3.4. Market Developments
- 11.3.3.5. Market Strategy
- 11.3.4. Beximco Pharma Ltd.
- 11.3.4.1. Overview
- 11.3.4.2. Segments and Type
- 11.3.4.3. Key Financials
- 11.3.4.4. Market Developments
- 11.3.4.5. Market Strategy
- 11.3.5. GlaxoSmithKline Pharmaceuticals Ltd.
- 11.3.5.1. Overview
- 11.3.5.2. Segments and Type
- 11.3.5.3. Key Financials
- 11.3.5.4. Market Developments
- 11.3.5.5. Market Strategy
- 11.3.6. 3M Pharmaceuticals Pty Ltd.
- 11.3.6.1. Overview
- 11.3.6.2. Segments and Type
- 11.3.6.3. Key Financials
- 11.3.6.4. Market Developments
- 11.3.6.5. Market Strategy
- 11.3.7. Biocare Manufacturing Sdn Bhd.
- 11.3.7.1. Overview
- 11.3.7.2. Segments and Type
- 11.3.7.3. Key Financials
- 11.3.7.4. Market Developments
- 11.3.7.5. Market Strategy
- 11.3.8. Anomatic Innovation & Design Center & Manufacturing
- 11.3.8.1. Overview
- 11.3.8.2. Segments and Type
- 11.3.8.3. Key Financials
- 11.3.8.4. Market Developments
- 11.3.8.5. Market Strategy
- 11.3.9. Aristo Pharma Ltd.
- 11.3.9.1. Overview
- 11.3.9.2. Segments and Type
- 11.3.9.3. Key Financials
- 11.3.9.4. Market Developments
- 11.3.9.5. Market Strategy
- 11.3.1. Cipla Inc.
12. Appendix
- 12.1. Research Methodology
- 12.2. Research Assumptions
- 12.3. Acronyms and Abbreviations
